Context: Control of plasma glucose could prevent the progression of most of the complications of diabetes and hemoglobinA1c (HbA1c) is the most important criterion controlling these long-term complications. Aims: This study was performed to assess the effect of fasting plasma glucose (FPG) and two- hour postprandial plasma glucose (2hpp) levels on HbA1c. Materials and Methods: In this descriptive, cross-sectional study; 300 patients were enrolled, assessed, and followed up at the clinic of the Diabetic Center of the University of Medical Science, Hamadan, Iran. All studied patients were diagnosed type 1 or 2 diabetes mellitus. Sampling was performed; we assessed FPG and 2hpp plasma glucose at baseline and at every two weeks to one month-as needed. HbA1c was assessed at the end of study. Results were analyzed by Pierson Covariance and Multiple Regression methods. Results: The mean plasma glucose in three groups of HbA1c (good to fair) were 148.5 56.80 mg/dl at fasting, and 199.70 53.01 mg/dl at two hours after breakfast (2hpp) and mean concentration of HbA1c were 8.41 1.1 . The plasma glucose level and HbA1c were 0.312 for fasting and, 0.416 for 2hpp at covariant value. Conclusion: The postprandial (after breakfast) plasma glucose has closer association to glycosylated hemoglobin than fasting plasma glucose, therefore evaluating postprandial plasma glucose should be our focus.
机构:
Paris Nord Univ, Dept Endocrinol Diabetol Nutr, Jean Verdier Hosp, APHP,CRNH IdF,CINFO, Bondy, FranceParis Nord Univ, Dept Endocrinol Diabetol Nutr, Jean Verdier Hosp, APHP,CRNH IdF,CINFO, Bondy, France
Valensi, Paul
Husemoen, Lise Lotte N.
论文数: 0引用数: 0
h-index: 0
机构:
Novo Nordisk AS, Copenhagen, DenmarkParis Nord Univ, Dept Endocrinol Diabetol Nutr, Jean Verdier Hosp, APHP,CRNH IdF,CINFO, Bondy, France
Husemoen, Lise Lotte N.
Weatherall, James
论文数: 0引用数: 0
h-index: 0
机构:
Novo Nordisk Inc, Princeton, NJ USAParis Nord Univ, Dept Endocrinol Diabetol Nutr, Jean Verdier Hosp, APHP,CRNH IdF,CINFO, Bondy, France
Weatherall, James
Monnier, Louis
论文数: 0引用数: 0
h-index: 0
机构:
Univ Montpellier, Inst Clin Res, Montpellier, FranceParis Nord Univ, Dept Endocrinol Diabetol Nutr, Jean Verdier Hosp, APHP,CRNH IdF,CINFO, Bondy, France
机构:
Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USAEli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
Bastyr, EJ
Stuart, CA
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
Stuart, CA
Brodows, RG
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
Brodows, RG
Schwartz, S
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
Schwartz, S
Graf, CJ
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
Graf, CJ
Zagar, A
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
Zagar, A
Robertson, KE
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
机构:
Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Peoples R ChinaNanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Peoples R China
Yang, T.
Yu, D.
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Peoples R ChinaNanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Peoples R China
Yu, D.
Zhou, H.
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Peoples R ChinaNanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Peoples R China
Zhou, H.
Zhu, G.
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Peoples R ChinaNanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Peoples R China